Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immediate versus delayed allopurinol initiation during an acute gout flare
ACTRN12612001188820Phase 4Recruiting
- Sponsor
- Department of General Practice and Primary Health Care, School of Population Health
- Start
- Sep 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of allopurinol in gout (2 arms), sponsored by Department of General Practice and Primary Health Care, School of Population Health. Primary endpoints: Pain at 6 weeks and Frequency of gout flares requiring treatment. Started Sep 2012; status: recruiting.
02
Drugs
allopurinol
03
Conditions
gout
Beyond the preview
Go deeper on ACTRN12612001188820.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12612001188820.